LQAI0.410%
as of Jul 17
NTRA
GrowthNATERA INC.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions.
Close · 3M
+13.62%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals2
Win rate50% (1/2)
Avg buy return+6.43%
LQAI · New entry · 1d
weight 0 → 0.420% (new)·stock up 44.4% in the 30 days before
Jul 7·entry $281.27·now $262.63Fresh
-6.63%
since Jul 7
LQAI · Exit · 1d
The AI ETF likely removed NTRA due to a swift reassessment of its risk-reward profile, as the algorithm probably detected deteriorating fundamental or technical signals warranting immediate divestment. This proactive sell-off suggests the AI identified a significant negative trigger after a period of price volatility. For retail investors, this highlights the dynamic and data-driven nature of AI fund management, underscoring the critical need to establish clear exit strategies and conduct continuous due diligence rather than holding assets indefinitely.
weight 0.360% → 0 (exited)·stock up 1.1% in the 30 days before
May 12·entry $204.21·now $262.63
+28.61%
since May 12
LQAI · Weight increase · 2d
The AI ETF's consecutive weight increase in NTRA likely indicates its algorithms detected a strengthening positive trend or improving outlook for the company. This sustained increase suggests the AI found compelling fundamental or technical signals, such as strong momentum or an improved risk-reward profile according to its models. Retail investors should view this as a prompt to conduct independent due diligence into NTRA's recent developments and financial news. It highlights a stock warranting closer examination, but not necessarily immediate action without personal research.
weight 0.390% → 0.410% (+0.020 pp)·stock up 4.3% in the 30 days before
May 7·entry $219.82·now $262.63Chased
+19.48%
since May 7
LQAI · Weight decrease · 2d
The AI ETF likely detected deteriorating financial fundamentals, persistent negative technical indicators, or a significant shift in market sentiment for NATERA INC., prompting a gradual de-risking of its position through consecutive weight reductions. For a retail investor, this pattern serves as a critical signal to conduct thorough independent due diligence into NTRA's recent performance and news, carefully re-evaluating their own investment thesis or the stock's increased risk profile.
weight 0.400% → 0.380% (-0.020 pp)·stock up 4.2% in the 30 days before
Apr 29·entry $194.75·now $262.63
+34.85%
since Apr 29
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.